In this episode of Med Tech Talks, Robert Klupacs CEO of the Bionics Institute, a world leader in the development of medical devices, talks to CEO of Synchron about the persistence and perspiration needed to build an innovative idea into a thriving med tech start-up, and gives advice to fellow entrepreneurs.

This series is dedicated to understanding what drives successful and impactful innovation in medical technology, and you would be hard-pressed to find someone as fitting for us to have as a guest on this podcast than Associate Professor Tom Oxley, who kindly joined us from New York. 

As well as being a renowned interventional neurologist at Mount Sinai Hospital in New York, Tom is the founder and CEO of Synchron, a company that specialises in neural interface technology.  Synchron was born from Tom’s great innovation, the Stentrode, an implantable medical device that can translate brain thought signals from the inside of a blood vessel.  

Thoughts captured from users of the stentrode are translated wirelessly digital devices designed to stimulate thought-controlled movement, which could transform the lives of people who are paralysed or have severely restricted movement. 

In this episode you will hear about:

• The story of Synchron
• Sourcing start-up funding and tips for people in med tech
• Tom's thoughts on building Australia from innovation 

More information
Take a look at the Synchron website: www.synchron.com

 To find out more about commercialisation of research through medical device spin-off companies at the Bionics Institute, go to: Our Impact  

Updated version 05/08/22